Detection of precancerous cervical lesions is differential by human papillomavirus type.
about
The influence of type-specific human papillomavirus infections on the detection of cervical precancer and cancer: A population-based study of opportunistic cervical screening in the United States.Clinical evaluation of the cartridge-based GeneXpert human papillomavirus assay in women referred for colposcopyExpression of geminin, p16, and Ki67 in cervical intraepithelial neoplasm and normal tissuesHuman papillomavirus genotypes in cervical intraepithelial neoplasia grade 3Evaluation of the polyclonal ELISA HPV serology assay as a biomarker for human papillomavirus exposureLong-term CIN3+ risk in women with abnormal cytology; role of hrHPV testing.Cost-effectiveness of using human papillomavirus 16/18 genotype triage in cervical cancer screening.Distribution of HPV Genotype in Invasive Cervical Carcinoma and Cervical Intraepithelial Neoplasia in Zhejiang Province, Southeast China: Establishing the Baseline for SurveillancePotential impact of a nine-valent vaccine in human papillomavirus related cervical disease.Human Papillomavirus Genotype Distribution in Invasive Cervical Cancer in PakistanDifferences in human papillomavirus type distribution in high-grade cervical intraepithelial neoplasia and invasive cervical cancer in Europe.Factors influencing decisions about surgical treatment of cervical precancerous lesions.Clinical value of fully automated p16/Ki-67 dual staining in the triage of HPV-positive women in the Norwegian Cervical Cancer Screening Program.HPV16 genotype, p16/Ki-67 dual staining and koilocytic morphology as potential predictors of the clinical outcome for cervical low-grade squamous intraepithelial lesions.Distribution of human papillomavirus genotypes in cervical intraepithelial neoplasia and invasive cervical cancer in Canada
P2860
Q30409120-E72070CD-FC0A-45BE-81E1-1AEDA6DFE938Q30412457-A9C19983-CFDE-4171-9D94-F4DC58CC47A3Q33879746-3847E949-897A-4E0C-BC4D-0CFC65C733BDQ33984185-E176ECC0-55DA-489D-A4A6-D5E227E37F8FQ35228757-F011CF4F-029F-4899-B81F-7E3C13625986Q35835177-080C35DD-8C0A-4A79-9363-CD4299D7F397Q36057298-32A7BB71-3348-4BEF-8C69-DB1181E27575Q36102386-1513BFCB-AEBE-45D7-A502-6457336C7F6EQ36560944-82171C50-336C-457D-A8C8-178080BB527CQ37208823-7C0BD49A-A056-48CA-94BB-1049DCD6D17AQ38023288-424AA311-BBEE-4CFD-8398-AD113C957540Q38190107-8D87EB3C-40E7-4750-99B9-05B174896B1BQ40423402-BCFC4D56-33CB-4D1E-99BF-6E83958ECED5Q42254022-9303FC2E-5B86-4835-B0DE-C008C9476B69Q57089348-721E5457-C24E-4DA8-BD0B-1FD58BBD6912
P2860
Detection of precancerous cervical lesions is differential by human papillomavirus type.
description
2009 nî lūn-bûn
@nan
2009 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Detection of precancerous cervical lesions is differential by human papillomavirus type.
@ast
Detection of precancerous cervical lesions is differential by human papillomavirus type.
@en
type
label
Detection of precancerous cervical lesions is differential by human papillomavirus type.
@ast
Detection of precancerous cervical lesions is differential by human papillomavirus type.
@en
prefLabel
Detection of precancerous cervical lesions is differential by human papillomavirus type.
@ast
Detection of precancerous cervical lesions is differential by human papillomavirus type.
@en
P2093
P2860
P50
P1433
P1476
Detection of precancerous cervical lesions is differential by human papillomavirus type.
@en
P2093
Diane Solomon
Julia Gage
Philip E Castle
P2860
P304
P356
10.1158/0008-5472.CAN-08-4192
P407
P577
2009-04-07T00:00:00Z